PHILADELPHIA/PARIS (Reuters) - France’s Sanofi-Aventis on Sunday publicly disclosed its $18.5 billion, $69-per-share cash offer for Genzyme Corp in a bid to rouse shareholders after failing to engage the U.S. biotechnology company in merger talks.
LONDON (Reuters) - An international scientific team has identified for the first time a genetic risk factor associated with common migraines and say their research could open the way for new treatments to prevent migraine attacks.
STOCKHOLM (Reuters) - Giving patients with a history of heart attacks a margarine enriched with omega-3 oils in addition to standard drugs appears to make no difference to their chances of having a repeat attack.
STOCKHOLM (Reuters) - Gene testing is shaping up to be a marketing battleground for new blood thinners like AstraZeneca’s Brilinta, underscoring the power and limitations of genetics as a tool to predict medical outcomes.
STOCKHOLM (Reuters) - Patients with chronic heart failure given injections of their own bone marrow stem cells have better heart function and live longer, German researchers said Sunday.
CHICAGO (Reuters) - U.S. birth rates in 2009 declined for the second straight year, a sign the economy may be causing some women to think twice about having children, U.S. health officials said on Friday.
STOCKHOLM (Reuters) - Cutting medicine prices and promoting cheap generics in the way European governments are now doing could jeopardize the long-term supply of new heart drugs, a top cardiologist said on Saturday.
LONDON (Reuters) - Rates of oesophageal cancer in men have risen by 50 percent in Britain in a generation, an increase that is probably being driven in part by growing rates of obesity and poor diet, scientists said on Saturday.
WASHINGTON (Reuters) - The U.S. Food and Drug Administration is cracking down on use of certain clinical trials that show a new drug is no worse than another already on the market, according to a government report released on Friday.
PHILADELPHIA (Reuters Health) - It was a cold, drizzly March morning this year when Ed Sproull’s heart stopped beating.